

Emmarlinkpharma Profile
Key Indicators
- Authorised Capital ₹ 7.30 Cr
- Paid Up Capital ₹ 6.41 Cr
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.27 Cr
- Satisfied Charges ₹ 15.00 Cr
- Revenue Growth 16.45%
- Profit Growth 0.37%
- Ebitda 11.58%
- Net Worth 10.21%
- Total Assets 37.29%
About Emmarlinkpharma
Emmarlinkpharma Private Limited (EPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 March 2019 (Six years and one month 15 days old ). Its registered office is in Kannur, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.30 Cr and a paid-up capital of Rs 6.41 Cr.
The company currently has active open charges totaling ₹20.27 Cr. The company has closed loans amounting to ₹15.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishnan Varayil, Girija Ramakrishnan, Aishwarya Praveen, and Two other members serve as directors at the Company.
Company Details
- Location
Kannur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999KL2019PTC057236
- Company No.
057236
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Emmarlinkpharma?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramakrishnan Varayil ![]() | Director | 24-Jan-2022 | Current |
Girija Ramakrishnan ![]() | Director | 19-Mar-2019 | Current |
Aishwarya Praveen ![]() | Director | 19-Mar-2019 | Current |
Praveen Damodar ![]() | Director | 19-Mar-2019 | Current |
Makkuni Ramakrishnan ![]() | Director | 19-Mar-2019 | Current |
Financial Performance of Emmarlinkpharma.
Emmarlinkpharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.45% increase. The company also saw a slight improvement in profitability, with a 0.37% increase in profit. The company's net worth Soared by an impressive increase of 10.21%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Emmarlinkpharma?
In 2023, Emmarlinkpharma had a promoter holding of 88.37% and a public holding of 11.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Emmarlink Distributors Private Limited
Ramakrishnan Varayil and Girija Ramakrishnan are mutual person
- Emmar Drug Links Private Limited
Ramakrishnan Varayil, Girija Ramakrishnan and 1 more are mutual person
- Kanhangad Links Private Limited
Girija Ramakrishnan and Praveen Damodar are mutual person
Charges (Loans)
₹20.27 Cr
₹15.00 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 20.20 Cr
- Dhanlaxmi Bank Limited : 0.07 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
10 May 2024 | Axis Bank Limited | ₹0.90 M | Open |
10 Jan 2024 | Dhanlaxmi Bank Limited | ₹0.68 M | Open |
12 May 2022 | Axis Bank Limited | ₹2.25 Cr | Open |
07 Mar 2022 | Axis Bank Limited | ₹17.86 Cr | Open |
18 Aug 2021 | Others | ₹8.50 Cr | Satisfied |
How Many Employees Work at Emmarlinkpharma?
Unlock and access historical data on people associated with Emmarlinkpharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Emmarlinkpharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emmarlinkpharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Emmarlinkpharma
Recent activity within the organization
- Annual General Meeting
Emmarlinkpharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Axis Bank Limited amounted to Rs. 0.09 Cr with Charge ID 100925375 was registered on 10 May 2024.
- Balance Sheet
Emmarlinkpharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
- Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100858586 was registered on 10 Jan 2024.
- Charges
A charge with Axis Bank Limited of Rs. 17.86 Cr registered on 07 Mar 2022 with Charge ID 100574462 was modified on 05 Jul 2023.
- Charges
A charge registered on 18 Aug 2021 via Charge ID 100509436 with Others was fully satisfied on 19 Jun 2023.
Frequently asked questions
What is the Incorporation or founding date of Emmarlinkpharma Private Limited?
Emmarlinkpharma Private Limited was incorporated on 19 Mar 2019.
What is authorized share capital and paid-up capital of Emmarlinkpharma Private Limited?
The authorized share capital of Emmarlinkpharma Private Limited is ₹ 7.30 Cr and paid-up capital is ₹ 6.41 Cr.
Who are the current board members & directors of Emmarlinkpharma Private Limited?
Currently 5 directors are associated with Emmarlinkpharma Private Limited.
- Ramakrishnan Makuni Varayil
- Girija Ramakrishnan
- Aishwarya Praveen
- Praveen Damodar
- Makkuni Amritha Ramakrishnan
What is the registered address of Emmarlinkpharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Emmarlinkpharma Private Limited is Building No. 52/5287 Haji Building, Fort Road India, Kannur, Kerala, 670001.
What is the corporate identification number (CIN) and company number of Emmarlinkpharma Private Limited?
The corporate identification number (CIN) of Emmarlinkpharma Private Limited is U74999KL2019PTC057236 and the company number is 057236 as per Ministry of Corporate Affairs (MCA).
What is the official website of Emmarlinkpharma Private Limited?
The Official website of Emmarlinkpharma Private Limited is https://www.emmarlink.com
What has been the recent revenue trend for Emmarlinkpharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Emmarlinkpharma Private Limited has risen by 16.45%.
What change has been observed in the net worth of Emmarlinkpharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Emmarlinkpharma Private Limited has experienced an upsurge of 10.21%.
What are the total open charges for Emmarlinkpharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Emmarlinkpharma Private Limited amount to ₹ 20.27 Cr.
When was the last Balance Sheet of Emmarlinkpharma Private Limited filed with the ROC?
The most recent Balance Sheet for Emmarlinkpharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records